Monash IVF Group Limited
MNIVF
$0.40
-$0.11-21.57%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 176.16M | 176.59M | 177.81M | 173.06M | 167.21M |
| Total Other Revenue | 2.20K | 77.90K | 153.00K | 163.70K | 173.90K |
| Total Revenue | 176.16M | 176.67M | 177.96M | 173.22M | 167.38M |
| Cost of Revenue | 117.62M | 117.94M | 118.79M | 115.33M | 111.14M |
| Gross Profit | 58.54M | 58.73M | 59.18M | 57.89M | 56.24M |
| SG&A Expenses | 15.40M | 14.57M | 13.81M | 13.72M | 13.54M |
| Depreciation & Amortization | 14.25M | 13.65M | 13.11M | 12.69M | 12.18M |
| Other Operating Expenses | 119.60K | 14.99M | 29.85M | 31.73M | 33.63M |
| Total Operating Expenses | 147.39M | 161.15M | 175.57M | 173.47M | 170.50M |
| Operating Income | 28.77M | 15.52M | 2.40M | -246.80K | -3.12M |
| Income Before Tax | 23.56M | 10.48M | -2.50M | -4.70M | -7.10M |
| Income Tax Expenses | 6.82M | 2.62M | -1.54M | -2.30M | -3.12M |
| Earnings from Continuing Operations | 16.74 | 7.86 | -0.96 | -2.40 | -3.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -431.40K | -466.80K | -504.40K | -443.50K | -380.00K |
| Net Income | 16.31M | 7.39M | -1.46M | -2.84M | -4.36M |
| EBIT | 28.77M | 15.52M | 2.40M | -246.80K | -3.12M |
| EBITDA | 39.52M | 25.95M | 12.55M | 9.48M | 6.10M |
| EPS Basic | 0.04 | 0.02 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.04 | 0.02 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.04 | 0.02 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.04 | 0.02 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B |
| Average Diluted Shares Outstanding | 1.57B | 1.57B | 1.57B | 1.57B | 1.56B |
| Dividend Per Share | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 |
| Payout Ratio | 78.84% | 173.56% | -878.76% | -438.72% | -275.59% |